5 Most Promising Cancer Stocks According to Analysts

Page 5 of 5

1. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Latest Analyst Share Price Upside: 162.47%

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)’s treatments target a variety of cancers such as cervical cancer, lung cancer, and melanoma. The firm’s shares are rated Strong Buy on average and analysts have set an average share price target of $20.42.

31 out of the 910 hedge funds surveyed by Insider Monkey had held a stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) during Q3 2023. Mark Rachesky’s MHR Fund Management was the biggest investor through its $90.9 million investment.

Follow Iovance Biotherapeutics Inc. (NASDAQ:IOVA)

Disclosure: None. You can also take a look at 11 Best Fundamentally Strong Penny Stocks To Invest In and 13 Best Holding Company Stocks To Invest In.

Follow Insider Monkey on Twitter

Page 5 of 5